Among patients with non–ST-segment elevation acute coronary syndromes who were scheduled to undergo catheterization, pretreatment with prasugrel did not reduce the rate of major ischemic events up to 30 days but increased the rate of major bleeding complications. These results should refine the pre-catheterisation and pre-hospitalisation strategy of the NSTE acute coronary syndromes nejm.org/doi/full/10.1056/NEJMoa1308075?query=featured_home
Posted on: Sun, 01 Sep 2013 14:17:38 +0000
Trending Topics
Recently Viewed Topics
© 2015